# HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance

> **NCT01769833** · PHASE3 · UNKNOWN · sponsor: **Pusan National University Hospital** · enrollment: 144 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** PEG-interferon-Alfa-2A
- **DRUG:** Nucleosides

## Key facts

- **NCT ID:** NCT01769833
- **Lead sponsor:** Pusan National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2015-05
- **Final completion:** 2016-05
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2014-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01769833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01769833, "HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT01769833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*